Avalere Health welcomes Kelsey Lang as a Principal to its Policy practice. Her experience working with providers, plans, and pharmaceutical manufacturers will help clients navigate the evolving policy landscape, particularly with respect to coverage and reimbursement issues in Medicare and other government programs.

“Kelsey is a veteran health policy expert and a thoughtful leader who will boost Avalere’s capabilities across a wide range of healthcare issues,” said Miryam Frieder, practice director. “She joins our team at a critical time when we are supporting our clients with the most significant drug pricing reforms in recent years.”

About Kelsey Lang

Kelsey Lang joins Avalere as a principal in Health Policy, bringing her extensive experience on coverage, access, and reimbursement, with a particular focus on Medicare and other government programs.

Before joining Avalere, Kelsey served as head of Policy at Novo Nordisk, where she led efforts to expand access to anti-obesity medicines, shape 340B policy strategy, and position the company for the Inflation Reduction Act and other drug pricing policies. Previously, she served as a director of Federal Policy and Government Affairs at Bristol Myers Squibb, where she led development of policy positions on a range of topics and engaged with trade associations, patient advocates, and policymakers. She was a deputy vice president at PhRMA and spearheaded its work on Medicare Part B and the Center for Medicare and Medicaid Innovation, and she held policy roles at the American Academy of Ophthalmology and URAC.

“I can’t think of a more exciting and dynamic time to join Avalere,” said Kelsey, “and I look forward to working with the talented team here to help our clients navigate the rapidly changing coverage and reimbursement landscape in Medicare Part B, Part D, and other government programs.”

Kelsey holds an MPP in health policy from Georgetown University and a BA in women’s studies from The George Washington University.